Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2023 | INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG) | BMC CANCER |